| Year |
Citation |
Score |
| 2014 |
Amsterdam A, Raanan C, Polin N, Melzer E, Givol D, Schreiber L. Modulation of c-kit expression in pancreatic adenocarcinoma: a novel stem cell marker responsible for the progression of the disease. Acta Histochemica. 116: 197-203. PMID 23978330 DOI: 10.1016/J.Acthis.2013.07.002 |
0.303 |
|
| 2013 |
Amsterdam A, Raanan C, Schreiber L, Freyhan O, Fabrikant Y, Melzer E, Givol D. Differential localization of LGR5 and Nanog in clusters of colon cancer stem cells. Acta Histochemica. 115: 320-9. PMID 23098761 DOI: 10.1016/J.Acthis.2012.09.003 |
0.335 |
|
| 2013 |
Amsterdam A, Raanan C, Schreiber L, Freyhan O, Schechtman L, Givol D. Localization of the stem cell markers LGR5 and Nanog in the normal and the cancerous human ovary and their inter-relationship. Acta Histochemica. 115: 330-8. PMID 23092806 DOI: 10.1016/J.Acthis.2012.09.004 |
0.308 |
|
| 2012 |
D'Orazi G, Givol D. p53 reactivation: the link to zinc. Cell Cycle (Georgetown, Tex.). 11: 2581-2. PMID 22751437 DOI: 10.4161/Cc.21020 |
0.374 |
|
| 2012 |
Margalit O, Simon AJ, Yakubov E, Puca R, Yosepovich A, Avivi C, Jacob-Hirsch J, Gelernter I, Harmelin A, Barshack I, Rechavi G, D'Orazi G, Givol D, Amariglio N. Zinc supplementation augments in vivo antitumor effect of chemotherapy by restoring p53 function. International Journal of Cancer. Journal International Du Cancer. 131: E562-8. PMID 21932419 DOI: 10.1002/Ijc.26441 |
0.319 |
|
| 2011 |
Sheffer M, Simon AJ, Jacob-Hirsch J, Rechavi G, Domany E, Givol D, D'Orazi G. Genome-wide analysis discloses reversal of the hypoxia-induced changes of gene expression in colon cancer cells by zinc supplementation. Oncotarget. 2: 1191-202. PMID 22202117 DOI: 10.18632/Oncotarget.395 |
0.346 |
|
| 2011 |
Puca R, Nardinocchi L, Porru M, Simon AJ, Rechavi G, Leonetti C, Givol D, D'Orazi G. Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs. Cell Cycle (Georgetown, Tex.). 10: 1679-89. PMID 21508668 DOI: 10.4161/Cc.10.10.15642 |
0.389 |
|
| 2010 |
Nardinocchi L, Pantisano V, Puca R, Porru M, Aiello A, Grasselli A, Leonetti C, Safran M, Rechavi G, Givol D, Farsetti A, D'Orazi G. Zinc downregulates HIF-1α and inhibits its activity in tumor cells in vitro and in vivo. Plos One. 5: e15048. PMID 21179202 DOI: 10.1371/Journal.Pone.0015048 |
0.309 |
|
| 2010 |
Nardinocchi L, Puca R, Givol D, D'Orazi G. Counteracting MDM2-induced HIPK2 downregulation restores HIPK2/p53 apoptotic signaling in cancer cells. Febs Letters. 584: 4253-8. PMID 20849851 DOI: 10.1016/J.Febslet.2010.09.018 |
0.339 |
|
| 2010 |
Puca R, Nardinocchi L, Givol D, D'Orazi G. Regulation of p53 activity by HIPK2: Molecular mechanisms and therapeutical implications in human cancer cells Oncogene. 29: 4378-4387. PMID 20514025 DOI: 10.1038/Onc.2010.183 |
0.373 |
|
| 2010 |
Nardinocchi L, Puca R, Givol D, D'Orazi G. HIPK2-a therapeutical target to be (re)activated for tumor suppression: role in p53 activation and HIF-1α inhibition. Cell Cycle (Georgetown, Tex.). 9: 1270-5. PMID 20234185 DOI: 10.4161/Cc.9.7.11125 |
0.352 |
|
| 2010 |
Yakubov E, Rechavi G, Rozenblatt S, Givol D. Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. Biochemical and Biophysical Research Communications. 394: 189-93. PMID 20188704 DOI: 10.1016/J.Bbrc.2010.02.150 |
0.321 |
|
| 2010 |
Puca R, Nardinocchi L, Starace G, Rechavi G, Sacchi A, Givol D, D'Orazi G. Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis. Free Radical Biology & Medicine. 48: 1338-46. PMID 20171273 DOI: 10.1016/J.Freeradbiomed.2010.02.015 |
0.323 |
|
| 2009 |
Puca R, Nardinocchi L, Sacchi A, Rechavi G, Givol D, D'Orazi G. HIPK2 modulates p53 activity towards pro-apoptotic transcription. Molecular Cancer. 8: 85. PMID 19828042 DOI: 10.1186/1476-4598-8-85 |
0.332 |
|
| 2009 |
Nardinocchi L, Puca R, Sacchi A, Rechavi G, Givol D, D'Orazi G. Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha. Plos One. 4: e6819. PMID 19714248 DOI: 10.1371/Journal.Pone.0006819 |
0.33 |
|
| 2009 |
Puca R, Nardinocchi L, Bossi G, Sacchi A, Rechavi G, Givol D, D'Orazi G. Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc. Experimental Cell Research. 315: 67-75. PMID 18996371 DOI: 10.1016/J.Yexcr.2008.10.018 |
0.37 |
|
| 2008 |
Lapi E, Di Agostino S, Donzelli S, Gal H, Domany E, Rechavi G, Pandolfi PP, Givol D, Strano S, Lu X, Blandino G. PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Molecular Cell. 32: 803-14. PMID 19111660 DOI: 10.1016/J.Molcel.2008.11.019 |
0.68 |
|
| 2008 |
Gal H, Pandi G, Kanner AA, Ram Z, Lithwick-Yanai G, Amariglio N, Rechavi G, Givol D. MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. Biochemical and Biophysical Research Communications. 376: 86-90. PMID 18765229 DOI: 10.1016/J.Bbrc.2008.08.107 |
0.638 |
|
| 2008 |
Puca R, Nardinocchi L, Gal H, Rechavi G, Amariglio N, Domany E, Notterman DA, Scarsella M, Leonetti C, Sacchi A, Blandino G, Givol D, D'Orazi G. Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown. Cancer Research. 68: 3707-14. PMID 18483253 DOI: 10.1158/0008-5472.Can-07-6776 |
0.712 |
|
| 2008 |
Kochupurakkal BS, Sarig R, Fuchs O, Piestun D, Rechavi G, Givol D. Nanog inhibits the switch of myogenic cells towards the osteogenic lineage. Biochemical and Biophysical Research Communications. 365: 846-50. PMID 18039466 DOI: 10.1016/J.Bbrc.2007.11.073 |
0.349 |
|
| 2007 |
Weizer-Stern O, Adamsky K, Margalit O, Ashur-Fabian O, Givol D, Amariglio N, Rechavi G. Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53. British Journal of Haematology. 138: 253-62. PMID 17593032 DOI: 10.1111/J.1365-2141.2007.06638.X |
0.338 |
|
| 2007 |
Gal H, Makovitzki A, Amariglio N, Rechavi G, Ram Z, Givol D. A rapid assay for drug sensitivity of glioblastoma stem cells. Biochemical and Biophysical Research Communications. 358: 908-13. PMID 17512905 DOI: 10.1016/J.Bbrc.2007.05.020 |
0.651 |
|
| 2006 |
Gal H, Amariglio N, Trakhtenbrot L, Jacob-Hirsh J, Margalit O, Avigdor A, Nagler A, Tavor S, Ein-Dor L, Lapidot T, Domany E, Rechavi G, Givol D. Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells. Leukemia. 20: 2147-54. PMID 17039238 DOI: 10.1038/Sj.Leu.2404401 |
0.678 |
|
| 2006 |
Piestun D, Kochupurakkal BS, Jacob-Hirsch J, Zeligson S, Koudritsky M, Domany E, Amariglio N, Rechavi G, Givol D. Nanog transforms NIH3T3 cells and targets cell-type restricted genes. Biochemical and Biophysical Research Communications. 343: 279-85. PMID 16540082 DOI: 10.1016/J.Bbrc.2006.02.152 |
0.376 |
|
| 2006 |
Lapi E, Iovino A, Fontemaggi G, Soliera AR, Iacovelli S, Sacchi A, Rechavi G, Givol D, Blandino G, Strano S. S100A2 gene is a direct transcriptional target of p53 homologues during keratinocyte differentiation. Oncogene. 25: 3628-37. PMID 16449968 DOI: 10.1038/Sj.Onc.1209401 |
0.387 |
|
| 2006 |
Enk CD, Jacob-Hirsch J, Gal H, Verbovetski I, Amariglio N, Mevorach D, Ingber A, Givol D, Rechavi G, Hochberg M. The UVB-induced gene expression profile of human epidermis in vivo is different from that of cultured keratinocytes. Oncogene. 25: 2601-14. PMID 16434974 DOI: 10.1038/Sj.Onc.1209292 |
0.685 |
|
| 2006 |
Margalit O, Amram H, Amariglio N, Simon AJ, Shaklai S, Granot G, Minsky N, Shimoni A, Harmelin A, Givol D, Shohat M, Oren M, Rechavi G. BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma. Blood. 107: 1599-607. PMID 16249378 DOI: 10.1182/Blood-2005-04-1629 |
0.392 |
|
| 2005 |
Toren A, Bielorai B, Jacob-Hirsch J, Fisher T, Kreiser D, Moran O, Zeligson S, Givol D, Yitzhaky A, Itskovitz-Eldor J, Kventsel I, Rosenthal E, Amariglio N, Rechavi G. CD133-positive hematopoietic stem cell "stemness" genes contain many genes mutated or abnormally expressed in leukemia. Stem Cells (Dayton, Ohio). 23: 1142-53. PMID 16140871 DOI: 10.1634/Stemcells.2004-0317 |
0.355 |
|
| 2005 |
Gerecht-Nir S, Dazard JE, Golan-Mashiach M, Osenberg S, Botvinnik A, Amariglio N, Domany E, Rechavi G, Givol D, Itskovitz-Eldor J. Vascular gene expression and phenotypic correlation during differentiation of human embryonic stem cells. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 232: 487-97. PMID 15614775 DOI: 10.1002/Dvdy.20247 |
0.36 |
|
| 2005 |
Golan-Mashiach M, Dazard JE, Gerecht-Nir S, Amariglio N, Fisher T, Jacob-Hirsch J, Bielorai B, Osenberg S, Barad O, Getz G, Toren A, Rechavi G, Itskovitz-Eldor J, Domany E, Givol D. Design principle of gene expression used by human stem cells: implication for pluripotency. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 147-9. PMID 15498892 DOI: 10.1096/Fj.04-2417Fje |
0.335 |
|
| 2005 |
Toren A, Bielorai B, Jacob-Hirsh J, Fisher T, Kreiser D, Zelikovsky S, Givol D, Itskovitz-Eldor J, Rosenthal E, Amariglio N, Rechavi G. CD133-positive hematopoietic stem cells “stemness” genes contain many genes mutated or abnormally expressed in leukemia Biology of Blood and Marrow Transplantation. 11: 85. DOI: 10.1016/J.Bbmt.2004.12.251 |
0.339 |
|
| 2004 |
Sredni B, Gal R, Cohen IJ, Dazard JE, Givol D, Gafter U, Motro B, Eliyahu S, Albeck M, Lander HM, Kalechman Y. Hair growth induction by the Tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras-dependent up-regulation of KGF expression. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 400-2. PMID 14656992 DOI: 10.1096/Fj.03-0552Fje |
0.31 |
|
| 2004 |
Toren A, Bielorai B, Jacob-Hirsch J, Fisher T, Zelikovsky S, Givol D, Domany E, Itskovitz-Eldor J, Kventsel I, Rosenthal E, Amariglio N, Rechavi G. Hematopoietic Stem Cells “Stemness” Genes Contain Many Genes Mutated or Abnormally Expressed in Hematopoietic Malignancies. Blood. 104: 4125-4125. DOI: 10.1182/Blood.V104.11.4125.4125 |
0.341 |
|
| 2003 |
Dazard JE, Gal H, Amariglio N, Rechavi G, Domany E, Givol D. Genome-wide comparison of human keratinocyte and squamous cell carcinoma responses to UVB irradiation: implications for skin and epithelial cancer. Oncogene. 22: 2993-3006. PMID 12771951 DOI: 10.1038/Sj.Onc.1206537 |
0.691 |
|
| 2003 |
Lotem J, Gal H, Kama R, Amariglio N, Rechavi G, Domany E, Sachs L, Givol D. Inhibition of p53-induced apoptosis without affecting expression of p53-regulated genes. Proceedings of the National Academy of Sciences of the United States of America. 100: 6718-23. PMID 12743373 DOI: 10.1073/Pnas.1031695100 |
0.684 |
|
| 2002 |
Fontemaggi G, Kela I, Amariglio N, Rechavi G, Krishnamurthy J, Strano S, Sacchi A, Givol D, Blandino G. Identification of direct p73 target genes combining DNA microarray and chromatin immunoprecipitation analyses. The Journal of Biological Chemistry. 277: 43359-68. PMID 12213815 DOI: 10.1074/Jbc.M205573200 |
0.397 |
|
| 2002 |
Rozenfeld-Granot G, Krishnamurthy J, Kannan K, Toren A, Amariglio N, Givol D, Rechavi G. A positive feedback mechanism in the transcriptional activation of Apaf-1 by p53 and the coactivator Zac-1. Oncogene. 21: 1469-76. PMID 11896574 DOI: 10.1038/Sj.Onc.1205218 |
0.386 |
|
| 2001 |
Kannan K, Kaminski N, Rechavi G, Jakob-Hirsch J, Amariglio N, Givol D. DNA microarray analysis of genes involved in p53 mediated apoptosis: Activation of Apaf-1 Oncogene. 20: 3449-3455. PMID 11423996 DOI: 10.1038/Sj.Onc.1204446 |
0.398 |
|
| 2001 |
Kannan K, Amariglio N, Rechavi G, Jakob-Hirsch J, Kela I, Kaminski N, Getz G, Domany E, Givol D. DNA microarrays identification of primary and secondary target genes regulated by p53 Oncogene. 20: 2225-2234. PMID 11402317 DOI: 10.1038/Sj.Onc.1204319 |
0.375 |
|
| 2001 |
Kannan K, Amariglio N, Rechavi G, Yaakov Y, Kaminski N, Getz G, Domany E, Givol D. Primary and secondary target genes regulated by p53 identified by DNA microarrays Nature Genetics. 27: 63-63. DOI: 10.1038/87146 |
0.337 |
|
| 2000 |
Kannan K, Givol D. FGF receptor mutations: Dimerization syndromes, cell growth suppression, and animal models Iubmb Life. 49: 197-205. PMID 10868910 DOI: 10.1080/713803609 |
0.317 |
|
| 2000 |
Kannan K, Amariglio N, Rechavi G, Givol D. Profile of gene expression regulated by induced p53: Connection to the TGF-β family Febs Letters. 470: 77-82. PMID 10722849 DOI: 10.1016/S0014-5793(00)01291-6 |
0.395 |
|
| 2000 |
Segev O, Chumakov I, Nevo Z, Givol D, Madar-Shapiro L, Sheinin Y, Weinreb M, Yayon A. Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3G380R transgenic mice Human Molecular Genetics. 9: 249-258. PMID 10607835 DOI: 10.1093/Hmg/9.2.249 |
0.316 |
|
| 1999 |
Wang Y, Blandino G, Givol D. Induced p21(waf) expression in H1299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicin Oncogene. 18: 2643-2649. PMID 10353608 DOI: 10.1038/Sj.Onc.1202632 |
0.357 |
|
| 1999 |
Wang Y, Spatz MK, Kannan K, Hayk H, Avivi A, Gorivodsky M, Pines M, Yayon A, Lonai P, Givol D. A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3 Proceedings of the National Academy of Sciences of the United States of America. 96: 4455-4460. PMID 10200283 DOI: 10.1073/Pnas.96.8.4455 |
0.303 |
|
| 1998 |
Wang Y, Blandino G, Oren M, Givol D. Induced p53 expression in lung cancer cell line promotes cell senescence and differentially modifies the cytotoxicity of anti-cancer drugs Oncogene. 17: 1923-1930. PMID 9788435 DOI: 10.1038/Sj.Onc.1202113 |
0.346 |
|
| 1998 |
Givol I, Givol D, Hughes SH. Overexpression of p21(waf1/cip1) arrests the growth of chicken embryo fibroblasts that overexpress E2F1 Oncogene. 16: 3115-3122. PMID 9671390 DOI: 10.1038/Sj.Onc.1201849 |
0.344 |
|
| 1995 |
Yayon A, Gray TE, Zimmer Y, Eisenstein M, Givol D. Ligand binding by fibroblast growth factor receptors investigated using chimeric receptor molecules Journal of Receptors and Signal Transduction. 15: 185-197. PMID 8903940 DOI: 10.3109/10799899509045216 |
0.307 |
|
| 1995 |
Blechman JM, Lev S, Barg J, Eisenstein M, Vaks B, Vogel Z, Givol D, Yarden Y.. The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction. Cell. 80: 103-113. PMID 7529140 DOI: 10.1016/0092-8674(95)90455-7 |
0.311 |
|
| 1994 |
Lev S, Blechman JM, Givol D, Yarden Y. Steel factor and c-kit protooncogene: Genetic lessons in signal transduction Critical Reviews in Oncogenesis. 5: 141-168. PMID 7531500 DOI: 10.1615/Critrevoncog.V5.I2-3.30 |
0.331 |
|
| 1993 |
Orr-Urtreger A, Bedford MT, Burakova T, Arman E, Zimmer Y, Yayon A, Givol D, Lonai P. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Developmental Biology. 158: 475-86. PMID 8393815 DOI: 10.1006/Dbio.1993.1205 |
0.342 |
|
| 1993 |
Avivi A, Yayon A, Givol D. A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III Febs Letters. 330: 249-252. PMID 8375495 DOI: 10.1016/0014-5793(93)80882-U |
0.324 |
|
| 1993 |
Blechman JM, Lev S, Givol D, Yarden Y. Structure-function analyses of the Kit receptor for the steel factor Stem Cells. 11: 12-21. PMID 7691317 DOI: 10.1002/Stem.5530110804 |
0.334 |
|
| 1993 |
Lev S, Blechman J, Nishikawa SI, Givol D, Yarden Y. Interspecies molecular chimeras of kit help define the binding site of the stem cell factor Molecular and Cellular Biology. 13: 2224-2234. PMID 7681144 DOI: 10.1128/Mcb.13.4.2224 |
0.337 |
|
| 1993 |
Yayon A, Aviezer D, Safran M, Gross JL, Heldman Y, Cabilly S, Givol D, Katchalski-Katzir E. Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library. Proceedings of the National Academy of Sciences of the United States of America. 90: 10643-7. PMID 7504274 DOI: 10.1073/Pnas.90.22.10643 |
0.345 |
|
| 1993 |
Balass M, Heldman Y, Cabilly S, Givol D, Katchalski-Katzir E, Fuchs S. Identification of a hexapeptide that mimics a conformation-dependent binding site of acetylcholine receptor by use of a phage-epitope library. Proceedings of the National Academy of Sciences of the United States of America. 90: 10638-42. PMID 7504273 DOI: 10.1073/Pnas.90.22.10638 |
0.324 |
|
| 1992 |
Cheadle C, Hook LE, Givol D, Ricca GA. Cloning and expression of the variable regions of mouse myeloma protein MOPC315 in E. coli: Recovery of active FV fragments Molecular Immunology. 29: 21-30. PMID 1731188 DOI: 10.1016/0161-5890(92)90152-N |
0.356 |
|
| 1992 |
Givol D, Yayon A. Complexity of FGF receptors: Genetic basis for structural diversity and functional specificity Faseb Journal. 6: 3362-3369. PMID 1464370 DOI: 10.1096/Fasebj.6.15.1464370 |
0.331 |
|
| 1992 |
Lev S, Givol D, Yarden Y. Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase Proceedings of the National Academy of Sciences of the United States of America. 89: 678-682. PMID 1370584 DOI: 10.1073/Pnas.89.2.678 |
0.321 |
|
| 1992 |
Yayon A, Zimmer Y, Shen GH, Avivi A, Yarden Y, Givol D. A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold. The Embo Journal. 11: 1885-90. PMID 1316275 DOI: 10.1002/J.1460-2075.1992.Tb05240.X |
0.32 |
|
| 1992 |
Shani M, Barash I, Nathan M, Ricca G, Searfoss GH, Dekel I, Faerman A, Givol D, Hurwitz DR. Expression of human serum albumin in the milk of transgenic mice Transgenic Research. 1: 195-208. PMID 1284483 DOI: 10.1007/Bf02524750 |
0.31 |
|
| 1991 |
Givol D. The minimal antigen-binding fragment of antibodies-Fv fragment Molecular Immunology. 28: 1379-1386. PMID 1749387 DOI: 10.1016/0161-5890(91)90040-Q |
0.318 |
|
| 1991 |
Lax I, Fischer R, Ng C, Segre J, Ullrich A, Givol D, Schlessinger J. Noncontiguous regions in the extracellular domain of EGF receptor define ligand-binding specificity. Cell Regulation. 2: 337-45. PMID 1716463 DOI: 10.1091/Mbc.2.5.337 |
0.309 |
|
| 1990 |
Sap J, D'Eustachio P, Givol D, Schlessinger J. Cloning and expression of a widely expressed receptor tyrosine phosphatase. Proceedings of the National Academy of Sciences of the United States of America. 87: 6112-6. PMID 2166945 DOI: 10.1073/Pnas.87.16.6112 |
0.311 |
|
| 1990 |
Lax I, Bellot F, Honegger AM, Schmidt A, Ullrich A, Givol D, Schlessinger J. Domain deletion in the extracellular portion of the EGF-receptor reduces ligand binding and impairs cell surface expression. Cell Regulation. 1: 173-88. PMID 2100196 DOI: 10.1091/Mbc.1.2.173 |
0.327 |
|
| 1990 |
Lev S, Yarden Y, Givol D. Receptor functions and ligand-dependent transforming potential of a chimeric kit proto-oncogene Molecular and Cellular Biology. 10: 6064-6068. PMID 1700279 DOI: 10.1128/Mcb.10.11.6064 |
0.333 |
|
| 1989 |
Amson R, Sigaux F, Przedborski S, Flandrin G, Givol D, Telerman A. The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias Proceedings of the National Academy of Sciences of the United States of America. 86: 8857-8861. PMID 2682662 DOI: 10.1073/Pnas.86.22.8857 |
0.308 |
|
| 1989 |
Ruta M, Burgess W, Givol D, Epstein J, Neiger N, Kaplow J, Crumley G, Dionne C, Jaye M, Schlessinger J. Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG). Proceedings of the National Academy of Sciences of the United States of America. 86: 8722-6. PMID 2554327 DOI: 10.1073/Pnas.86.22.8722 |
0.395 |
|
| 1988 |
Lax I, Johnson A, Howk R, Sap J, Bellot F, Winkler M, Ullrich A, Vennstrom B, Schlessinger J, Givol D. Chicken epidermal growth factor (EGF) receptor: cDNA cloning, expression in mouse cells, and differential binding of EGF and transforming growth factor alpha. Molecular and Cellular Biology. 8: 1970-8. PMID 3260329 DOI: 10.1128/Mcb.8.5.1970 |
0.306 |
|
| 1988 |
Lax I, Burgess WH, Bellot F, Ullrich A, Schlessinger J, Givol D. Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling Molecular and Cellular Biology. 8: 1831-1834. PMID 3260004 DOI: 10.1128/Mcb.8.4.1831 |
0.311 |
|
| 1988 |
Telerman A, Amson R, Zakut-Houri R, Givol D. Identification of the human pim-1 gene product as a 33-kilodalton cytoplasmic protein with tyrosine kinase activity Molecular and Cellular Biology. 8: 1498-1503. PMID 2837645 DOI: 10.1128/Mcb.8.4.1498 |
0.35 |
|
| 1987 |
Luria S, Gross G, Horowitz M, Givol D. Promoter and enhancer elements in the rearranged alpha chain gene of the human T cell receptor Embo Journal. 6: 3307-3312. PMID 3501368 DOI: 10.1002/J.1460-2075.1987.Tb02650.X |
0.335 |
|
| 1987 |
Zakut-Houri R, Hazum S, Givol D, Telerman A. The cDNA sequence and gene analysis of the human pim oncogene Gene. 54: 105-111. PMID 3475233 DOI: 10.1016/0378-1119(87)90352-0 |
0.346 |
|
| 1987 |
Gurfinkel N, Unger T, Givol D, Mushinski JF. Expression of the bcl-2 gene in mouse B lymphocytic cell lines is differentiation stage specific European Journal of Immunology. 17: 567-570. PMID 3106072 DOI: 10.1002/Eji.1830170421 |
0.331 |
|
| 1986 |
Isobe M, Emanuel BS, Givol D, Oren M, Croce CM. Localization of gene for human p53 tumour antigen to band 17p13 Nature. 320: 84-85. PMID 3456488 DOI: 10.1038/320084A0 |
0.335 |
|
| 1986 |
Arman E, Katzir N, Rechavi G, Givol D. Transposable elements and cancer Current Topics in Microbiology and Immunology. 132: 90-97. PMID 3024926 DOI: 10.1007/978-3-642-71562-4_12 |
0.302 |
|
| 1986 |
McBride OW, Merry D, Givol D. The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13) Proceedings of the National Academy of Sciences of the United States of America. 83: 130-134. PMID 3001719 DOI: 10.1073/Pnas.83.1.130 |
0.336 |
|
| 1985 |
Bienz-Tadmor B, Zakut-Houri R, Libresco S, Givol D, Oren M. The 5′ region of the p53 gene: evolutionary conservation and evidence for a negative regulatory element. The Embo Journal. 4: 3209-3213. DOI: 10.1002/J.1460-2075.1985.Tb04067.X |
0.373 |
|
| 1984 |
Czosnek HH, Bienz B, Givol D, Zakut-Houri R, Pravtcheva DD, Ruddle FH, Oren M. The gene and the pseudogene for mouse p53 cellular tumor antigen are located on different chromosomes. Molecular and Cellular Biology. 4: 1638-40. PMID 6387444 DOI: 10.1128/Mcb.4.8.1638 |
0.334 |
|
| 1984 |
Horowitz M, Luria S, Rechavi G, Givol D. Mechanism of activation of the mouse c-mos oncogene by the LTR of an intracisternal A-particle gene Embo Journal. 3: 2937-2941. PMID 6098457 DOI: 10.1002/J.1460-2075.1984.Tb02235.X |
0.321 |
|
| 1984 |
Eliyahu D, Raz A, Gruss P, Givol D, Oren M. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature. 312: 646-9. PMID 6095116 DOI: 10.1038/312646A0 |
0.342 |
|
| 1984 |
Bienz B, Zakut-Houri R, Givol D, Oren M. Analysis of the gene coding for the murine cellular tumour antigen p53. The Embo Journal. 3: 2179-2183. DOI: 10.1002/J.1460-2075.1984.Tb02110.X |
0.396 |
|
| 1983 |
Kuff EL, Feenstra A, Lueders K, Rechavi G, Givol D, Canaani E. Homology between an endogenous viral LTR and sequences inserted in an activated cellular oncogene Nature. 302: 547-548. PMID 6835385 DOI: 10.1038/302547A0 |
0.338 |
|
| 1983 |
Zakut-Houri R, Oren M, Bienz B, Lavie V, Hazum S, Givol D. A single gene and a pseudogene for the cellular tumour antigen p53 Nature. 306: 594-597. PMID 6646235 DOI: 10.1038/306594A0 |
0.384 |
|
| 1983 |
Cohen JB, Givol D. Allelic immunoglobulin VH genes in two mouse strains: possible germline gene recombination. The Embo Journal. 2: 2013-8. PMID 6416826 DOI: 10.1002/J.1460-2075.1983.Tb01693.X |
0.342 |
|
| 1983 |
Cohen JB, Givol D. Conservation and divergence of immunoglobulin VH pseudogenes. The Embo Journal. 2: 1795-800. PMID 6315403 DOI: 10.1002/J.1460-2075.1983.Tb01660.X |
0.305 |
|
| 1983 |
Bitoun R, Berman J, Zilberstein A, Holland D, Cohen JB, Givol D, Zamir A. Promoter mutations that allow nifA-independent expression of the nitrogen fixation nifHDKY operon. Proceedings of the National Academy of Sciences of the United States of America. 80: 5812-6. PMID 6310592 DOI: 10.1073/Pnas.80.19.5812 |
0.323 |
|
| 1983 |
Rechavi G, Ram D, Glazer L, Zakut R, Givol D. Evolutionary aspects of immunoglobulin heavy chain variable region (VH) gene subgroups. Proceedings of the National Academy of Sciences of the United States of America. 80: 855-9. PMID 6298778 DOI: 10.1073/Pnas.80.3.855 |
0.351 |
|
| 1983 |
Lonai P, Rechavi G, Arman E, Givol D. Retention and loss of immunoglobulin heavy chain alleles in helper T cell hybridoma clones Embo Journal. 2: 781-786. PMID 6227480 DOI: 10.1002/J.1460-2075.1983.Tb01500.X |
0.35 |
|
| 1983 |
Eshhar Z, Gigi O, Givol D, Ben-Neriah Y. Monoclonal anti-VH antibodies recognize a common VH determinant expressed on immunoglobulin heavy chains from various species. European Journal of Immunology. 13: 533-40. PMID 6191996 DOI: 10.1002/Eji.1830130704 |
0.334 |
|
| 1983 |
Oren M, Bienz B, Givol D, Rechavi G, Zakut R. Analysis of recombinant DNA clones specific for the murine p53 cellular tumor antigen. The Embo Journal. 2: 1633-1639. DOI: 10.1002/J.1460-2075.1983.Tb01637.X |
0.373 |
|
| 1982 |
Rechavi G, Bienz B, Ram D, Ben-Neriah Y, Cohen JB, Zakut R, Givol D. Organization and evolution of immunoglobulin VH gene subgroups. Proceedings of the National Academy of Sciences of the United States of America. 79: 4405-9. PMID 6812048 DOI: 10.1073/Pnas.79.14.4405 |
0.35 |
|
| 1982 |
Rechavi G, Givol D, Canaani E. Activation of a cellular oncogene by DNA rearrangement: Possible involvement of an IS-like element Nature. 300: 607-611. PMID 6292737 DOI: 10.1038/300607A0 |
0.335 |
|
| 1982 |
Cohen JB, Effron K, Rechavi G, Ben-Neriah Y, Zakut R, Givol D. Simple DNA sequences in homologous flanking regions near immunoglobulin VH genes: a role in gene interaction? Nucleic Acids Research. 10: 3353-70. PMID 6285297 DOI: 10.1093/Nar/10.11.3353 |
0.337 |
|
| 1981 |
Givol D, Zakut R, Effron K, Rechavi G, Ram D, Cohen JB. Diversity of germ-line immunoglobulin VH genes. Nature. 292: 426-30. PMID 6789211 DOI: 10.1038/292426A0 |
0.35 |
|
| 1981 |
Ben-Neriah Y, Cohen JB, Rechavi G, Zakut R, Givol D. Polymorphism of germ-line immunoglobulin VH genes correlates with allotype and idiotype markers. European Journal of Immunology. 11: 1017-20. PMID 6276186 DOI: 10.1002/Eji.1830111213 |
0.3 |
|
| 1981 |
Lonai P, Puri J, Bitton S, Ben-Neriah Y, Givol D, Hämmerling GJ. H-2-restricted helper factor secreted by clone hybridoma cells. The Journal of Experimental Medicine. 154: 942-51. PMID 6168725 DOI: 10.1084/Jem.154.3.942 |
0.323 |
|
| 1980 |
Neriah YB, Givol D, Lonai P, Simon MM, Eichmann K. Allotype-linked genetic control of a polymorphic VH framework determinant on mouse T-helper cell receptors Nature. 285: 257-259. PMID 6769052 DOI: 10.1038/285257A0 |
0.34 |
|
| 1980 |
Elliott BE, Nagy ZA, Takacs BJ, Ben-Neriah Y, Givol D. Antigen-binding receptors on T cells from long-term MLR. evidence of binding sites for allogeneic and self-MHC products. Immunogenetics. 11: 177-90. PMID 6447669 DOI: 10.1007/Bf01567783 |
0.344 |
|
| 1980 |
Elliott BE, Nagy ZA, Ben-Neriah Y, Givol D. Alloactivated Lyt 1 +2- T lymphoblasts bind syngeneic Ia antigens. Nature. 285: 496-8. PMID 6447251 DOI: 10.1038/285496A0 |
0.325 |
|
| 1980 |
Zakut R, Givol D, Mory YY. Structure of immunoglobulin γ2b heavy chain gene cloned from mouse embryo gene library Nucleic Acids Research. 8: 453-466. PMID 6255443 DOI: 10.1093/Nar/8.3.453 |
0.331 |
|
| 1980 |
Eshhar Z, Apte RN, Löwy I, Ben-Neriah Y, Givol D, Mozes E. T-cell hybridoma bearing heavy chain variable region determinants producing (T,G)-A--L-specific helper factor. Nature. 286: 270-2. PMID 6157102 DOI: 10.1038/286270A0 |
0.324 |
|
| 1980 |
Puri J, Ben-Neriah Y, Givol D, Lonai P. Antibodies to immunoglobulin heavy chain variable regions protect helper cells from specific suicide by radiolabeled antigen. European Journal of Immunology. 10: 281-4. PMID 6156844 DOI: 10.1002/Eji.1830100411 |
0.348 |
|
| 1980 |
Eichmann K, Ben-Neriah Y, Hetzelberger D, Polke C, Givol D, Lonai P. Correlated expression of VH framework and VH idiotypic determinants on T helper cells and on functionally undefined T cells binding group A streptococcal carbohydrate. European Journal of Immunology. 10: 105-12. PMID 6154580 DOI: 10.1002/Eji.1830100207 |
0.323 |
|
| 1979 |
Cramer M, Krawinkel U, Melchers I, Imanishi-Kari T, Ben-Neriah Y, Givol D, Rajewsky K. Isolated hapten-binding receptors of sensitized lymphocytes. IV. Expression of immunoglobulin variable regions in (4-hydroxy-3-nitrophenyl) acetyl (NP)-specific receptors isolated from murine B and T lymphocytes. European Journal of Immunology. 9: 332-8. PMID 111953 DOI: 10.1002/Eji.1830090415 |
0.358 |
|
| 1979 |
Ben-Neriah Y, Givol D, Gavish M. Anti-V region framework antibodies affect the ligand binding of VL dimer. European Journal of Immunology. 9: 91-3. PMID 108113 DOI: 10.1002/Eji.1830090119 |
0.306 |
|
| 1978 |
Gavish M, Zakut R, Wilchek M, Givol D. Preparation of a semisynthetic antibody Biochemistry. 17: 1345-1351. PMID 418802 DOI: 10.1021/Bi00600A032 |
0.312 |
|
| 1978 |
Lonai P, Ben-Neriah Y, Steinman L, Givol D. Selective participation of immunoglobulin V region and major histocompatibility complex products in antigen binding by T cells. European Journal of Immunology. 8: 827-32. PMID 103727 DOI: 10.1002/Eji.1830081202 |
0.346 |
|
| 1978 |
Ben-Neriah Y, Wuilmart C, Lonai P, Givol D. Preparation and characterization of anti-framework antibodies to the heavy chain variable region (VH) of mouse immunoglobulins. European Journal of Immunology. 8: 797-801. PMID 82512 DOI: 10.1002/Eji.1830081109 |
0.325 |
|
| 1978 |
Ben-Neriah Y, Lonai P, Gavish M, Givol D. Preparation and characterization of antibodies to the lambda chain variable region (Vlambda) of mouse immunoglobulins. European Journal of Immunology. 8: 792-6. PMID 82511 DOI: 10.1002/Eji.1830081108 |
0.327 |
|
| 1978 |
Schwartz M, Novick D, Givol D, Fuchs S. Induction of anti-idiotypic antibodies by immunisation with syngeneic spleen cells educated with acetylcholine receptor Nature. 273: 543-545. PMID 78451 DOI: 10.1038/273543A0 |
0.315 |
|
| 1977 |
Wuilmart C, Urbain J, Givol D. On the location of palindromes in immunoglobulin genes Proceedings of the National Academy of Sciences of the United States of America. 74: 2526-2530. PMID 267946 DOI: 10.1073/Pnas.74.6.2526 |
0.366 |
|
| 1977 |
Givol D, Wilchek M. [53] Affinity labeling of antibody combining sites as illustrated by anti-dinitrophenyl antibodies Methods in Enzymology. 46: 479-492. DOI: 10.1016/S0076-6879(77)46057-9 |
0.317 |
|
| 1976 |
Mozes E, Isac R, Givol D, Zakut R, Beitsch D. Characterization and specificity of a T-cell cooperative factor Advances in Experimental Medicine and Biology. 66: 397-402. PMID 1083645 DOI: 10.1007/978-1-4613-4355-4_61 |
0.302 |
|
| 1976 |
Sharon J, Givol D. Preparation of Fv fragment from the mouse myeloma XRPC-25 immunoglobulin possessing anti-dinitrophenyl activity Biochemistry. 15: 1591-1594. PMID 4096 DOI: 10.1021/Bi00652A033 |
0.301 |
|
| 1975 |
Matthyssens GE, Hurwitz E, Givol D, Sela M. Binding of histamine- and other ligand-conjugated macromolecules to lymphocytes Molecular and Cellular Biochemistry. 7: 119-126. PMID 1143285 DOI: 10.1007/Bf01792078 |
0.34 |
|
| 1975 |
Schlessinger J, Steinberg IZ, Givol D, Hochman J, Pecht I. Antigen-induced conformational changes in antibodies and their Fab fragments studied by circular polarization of fluorescence. Proceedings of the National Academy of Sciences of the United States of America. 72: 2775-9. PMID 1058492 DOI: 10.1073/Pnas.72.7.2775 |
0.309 |
|
| 1975 |
Jaton JC, Huser H, Braun DG, Givol D, Pecht I, Schlessinger J. Conformational changes induced in a homogeneous anti-type III pneumococcal antibody by oligosaccharides of increasing size. Biochemistry. 14: 5312-5. PMID 51 DOI: 10.1021/Bi00695A014 |
0.307 |
|
| 1973 |
Weinstein Y, Shaltiel S, Givol D, Strausbauch PH. The importance of the lysyl residue in goat anti-dinitrophenyl antibodies modified by site-directed reagents Immunochemistry. 10: 337-340. PMID 4581701 DOI: 10.1016/0019-2791(73)90081-5 |
0.324 |
|
| 1973 |
Hochman J, Inbar D, Givol D. An active antibody fragment (Fv) composed of the variable portions of heavy and light chains Biochemistry. 12: 1130-1135. PMID 4569769 DOI: 10.1021/Bi00730A018 |
0.31 |
|
| 1972 |
Pecht I, Givol D, Sela M. Dynamics of hapten-antibody interaction. Studies on a myeloma protein with anti-2, 4-dinitrophenyl specificity Journal of Molecular Biology. 68: 241-247. PMID 5069790 DOI: 10.1016/0022-2836(72)90211-2 |
0.335 |
|
| 1972 |
Haimovich J, Eisen HN, Hurwitz E, Givol D. Localization of affinity-labeled residues on the heavy and light chain of two myeloma proteins with anti-hapten activity Biochemistry. 11: 2389-2398. PMID 5064800 DOI: 10.1021/Bi00763A001 |
0.301 |
|
| 1972 |
Inbar D, Hochman J, Givol D. Localization of antibody-combining sites within the variable portions of heavy and light chains Proceedings of the National Academy of Sciences of the United States of America. 69: 2659-2662. PMID 4560694 DOI: 10.1073/Pnas.69.9.2659 |
0.327 |
|
| 1970 |
Strausbauch P, Sulica A, Givol D. General method for the detection of cells producing antibodies against haptens and proteins Nature. 227: 68-69. PMID 4912327 DOI: 10.1038/227068A0 |
0.329 |
|
| 1970 |
Haimovich J, Givol D, Eisen HN. Affinity labeling of the heavy and light chains of a myeloma protein with anti-2,4-dinitrophenyl activity Proceedings of the National Academy of Sciences of the United States of America. 67: 1656-1661. PMID 4099105 DOI: 10.1073/Pnas.67.4.1656 |
0.307 |
|
| 1970 |
Givol D, Haimovich J, Segal S, Globerson A, Feldman M. Specific Blocking of in vitro Antibody Response by Affinity Labeling Reagents Protides of the Biological Fluids. 17: 59-61. DOI: 10.1016/B978-0-08-015566-1.50012-5 |
0.337 |
|
| 1969 |
Weinstein Y, Wilchek M, Givol D. Affinity labeling of anti-dinitrophenyl antibodies with bromoacetyl derivatives of homologous haptens Biochemical and Biophysical Research Communications. 35: 694-701. PMID 5815818 DOI: 10.1016/0006-291X(69)90461-6 |
0.308 |
|
| 1969 |
Segal S, Globerson A, Feldman M, Haimovich J, Givol D. Specific blocking in vitro of antibody synthesis by affinity labelling reagents. Nature. 223: 1374-5. PMID 5809514 DOI: 10.1038/2231374A0 |
0.35 |
|
| 1969 |
Segal S, Givol D, Sela M. Disc electrophoresis patterns of the Fd fragment of rabbit immunoglobulin fractions and of purified antibodies Immunochemistry. 6. PMID 5778777 DOI: 10.1016/0019-2791(69)90159-1 |
0.302 |
|
| 1968 |
Jaton JC, Klinman NR, Givol D, Sela M. Recovery of antibody activity upon reoxidation of completely reduced polyalanyl heavy chain and its fd fragment derived from anti-2,4-dinitrophenyl antibody Biochemistry. 7: 4185-4195. PMID 4973471 DOI: 10.1021/Bi00852A008 |
0.319 |
|
| 1968 |
Fuchs S, Givol D. The effect of limited nitration on antibodies to dinitrophenyl group Febs Letters. 2: 45-48. DOI: 10.1016/0014-5793(68)80097-3 |
0.314 |
|
| Show low-probability matches. |